These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 5596960)
1. [Aminophenazone antibodies in a carditis in childhood--Contribution on the specificity of pharmacological agent reactions]. Wiersbitzky S; Seer RO; Wiersbitzky H Allerg Asthma (Leipz); 1967 Aug; 13(4):147-51. PubMed ID: 5596960 [No Abstract] [Full Text] [Related]
2. [Serious form of Schultz' agranulocytosis in a 3-year-old child]. Schmidt-Wiederkehr P; Gross-Selbeck G; Sachs V; Drescher J Dtsch Med Wochenschr; 1971 May; 96(21):908-10. PubMed ID: 4325540 [No Abstract] [Full Text] [Related]
3. [Aminophenazone as cause of allergic reactions (author's transl)]. Sorgo G Arch Toxicol; 1974; 32(2):131-41. PubMed ID: 4408030 [No Abstract] [Full Text] [Related]
4. [On immunopathology and serology of recurrent endomyocarditis]. Klein G Z Rheumaforsch; 1968 Dec; 27(11):411-7. PubMed ID: 4179699 [No Abstract] [Full Text] [Related]
10. [Allergic reactions to Kvater's mixture]. Rovinskiĭ VI Klin Med (Mosk); 1988 May; 66(5):121. PubMed ID: 3419089 [No Abstract] [Full Text] [Related]
11. [Autoimmunologic processes in mechanisms of development of experimental endomyocarditis]. Pletsityĭ DF; Aver'ianova LL Vestn Akad Med Nauk SSSR; 1967; 22(2):19-22. PubMed ID: 5621032 [No Abstract] [Full Text] [Related]
12. [Gougerot-Blum disease due to hypersensitivity to carbutamide]. Dobozy A; Hunyadi J; Husz S Z Hautkr; 1974 Dec; 49(23):1009-12. PubMed ID: 4450612 [No Abstract] [Full Text] [Related]
13. [Adverse drug reactions in patients at our Debrecen clinic]. Mészáros C Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):11-2. PubMed ID: 5798942 [No Abstract] [Full Text] [Related]
14. Immune mechanism of drug hypersensitivity. Pichler WJ Immunol Allergy Clin North Am; 2004 Aug; 24(3):373-97, v-vi. PubMed ID: 15242717 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical differentiation of eosinophilic heart diseases using antibodies against eosinophil activation markers. Grabellus F; Mall G; Schnabel PA; Wieneke H; Pfeifer U; Kersting C; Schmitz KJ; Wohlschläger J; Sigusch HH; Bierhoff E; Kamler M; Scheld HH; Baba HA Histopathology; 2005 Jan; 46(1):89-97. PubMed ID: 15656891 [TBL] [Abstract][Full Text] [Related]